Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
07/30/2004
Trade Name:
Claritin-D 12 Hour Extended-Release Tablets Claritin-D 24 Hour Extended-Release Tablets
Generic Name or Proper Name (*):
loratadine; pseudoephedrine
Indications Studied:
Temporary relief of nasal congestion due to the common cold in children 12 years of age and older OTC
Label Changes Summary:
* Approval based on monograph and previous studies for other indication * No new studies submitted * Studies in children birth - 12 years of age waived * New indication
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Schering-Plough
NNPS:
TRUE
Therapeutic Category:
Antihistamine
-
-